LinkedIn facebook twitter youtube
News archive
Recent news


More than 3.900 abstracts have been submitted to the European Society for Medical Oncology Congress (ESMO) Annual Congress which will be held from 27 September to 1st October 2019 in Barcelona, Spain.

For yet another year, Myeloma Patients Europe (MPE) will be attending this scientific meeting where the latest data on Oncology research and development will be presented.

If you are a myeloma patient advocate and you are planning to attend this congress, please find below all relevant myeloma and advocacy sessions that will be held at ESMO 2019.



The ESMO Patient Advocates Working Group (PAWG) organises a Patient Advocacy Apéro to network and learn about each other’s activities and project on Friday 27 September (17.30-19.00h – Foyer between rooms 1.2 and 1.3, Conference Centre 1, CC1 south access). Don’t miss it!

For more information about the congress and the Patient Advocacy Track, please find below the relevant links:

Recent news

» Myeloma diagnosis can take over 5 months and require more than 4 medical consultations with more than 3 different specialists

» The European Medicines Agency (EMA) approves Melflufen (Pepaxti®) for the treatment of refractory myeloma

Leave a Reply

Your email address will not be published.

I accept the Privacy Policy